Evolution of antibody immunity following Omicron BA.1 breakthrough infection

Mostrar otras versiones (1)

Understanding the evolution of antibody immunity following heterologous SAR-CoV-2 breakthrough infection will inform the development of next-generation vaccines. Here, we tracked SARS-CoV-2 receptor binding domain (RBD)-specific antibody responses up to six months following Omicron BA.1 breakthrough...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Chengzi I., Starr, Tyler N., Zhou, Panpan, Dugan, Haley L., Khalifé, Paul, Song, Ge, Champney, Elizabeth R., Mielcarz, Daniel W., Geoghegan, James C., Burton, Dennis R., Raiees, Andrabi, Bloom, Jesse D., Walker, Laura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516849/
https://www.ncbi.nlm.nih.gov/pubmed/36172124
http://dx.doi.org/10.1101/2022.09.21.508922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516849/
https://www.ncbi.nlm.nih.gov/pubmed/36172124
http://dx.doi.org/10.1101/2022.09.21.508922

Ejemplares similares